New Indication for Weight Loss Drug Semaglutide

被引：0
|
作者：
Aschenbrenner, Diane S. [1 ,2 ]
机构：
[1] Notre Dame Maryland Univ, Baltimore, MD 21210 USA
[2] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21205 USA
来源：
AMERICAN JOURNAL OF NURSING | 2023年 / 123卷 / 06期
关键词：
D O I：
10.1097/01.NAJ.0000938724.36679.23
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
The weight loss drug semaglutide (Wegovy) is now approved for pediatric patients ages 12 and older whose body mass index categorizes them as obese.
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [41] Improvement in PAH After Semaglutide-induced Weight Loss
    Funke, B. E.
    Pugh, M. E.
    Hemnes, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [42] Semaglutide vs Tirzepatide Dosages for Weight Loss-Reply
    Rodriguez, Patricia J.
    Gluckman, Ty J.
    Stucky, Nicholas
    JAMA INTERNAL MEDICINE, 2025, 185 (02) : 243 - 244
  • [43] Semaglutide Is Effective in Achieving Weight Loss in Liver Transplant Recipients
    Chow, Kenneth
    Ibrahim, Brittney
    Rahal, Kabir
    Hsu, Ryan
    Tan, Teresa
    Meneses, Katherine
    Saab, Sammy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1006 - S1007
  • [44] Semaglutide is effective in achieving weight loss in liver transplant recipients
    Chow, Kenneth W.
    Ibrahim, Brittney
    Rahal, Kabir
    Hsu, Ryan H.
    Tan, Teresa
    Meneses, Katherine
    Saab, Sammy
    LIVER TRANSPLANTATION, 2024, 30 (02) : 223 - 225
  • [45] Semaglutide for weight loss and cardiometabolic risk reduction in overweight/obesity
    Mares, Adriana C.
    Chatterjee, Saurav
    Mukherjee, Debabrata
    CURRENT OPINION IN CARDIOLOGY, 2022, 37 (04) : 350 - 355
  • [46] USING WEIGHT LOSS AS AN INDICATION OF DURATION OF ADHERENCE TO A LOW CARBOHYDRATE WEIGHT LOSS DIET
    Ibragimov, O.
    Paquette, M.
    Sahye-Pudaruth, S.
    Jenkins, D.
    Patel, D.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (SUPPL 1) : S46 - S46
  • [47] Weight It Out: Use of Semaglutide for Weight Loss in Patients Undergoing Lung Transplant Evaluation
    Stryker, K.
    Farghaly, S.
    Alsunaid, S.
    Joseph, J.
    Borgi, J.
    Forest, S.
    Mansour, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S500 - S500
  • [48] WEIGHT LOSS OR KIDNEY LOSS: AN AWARENESS OF OZEMPIC (SEMAGLUTIDE)-INDUCED ACUTE KIDNEY INJURY
    Khan, Fardil
    Abdelaziz, Mahmoud
    Wu, Ming
    Jhaveri, Kenar
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2025, 85 (04)
  • [49] NEW INDICATION FOR FAMILIAR DRUG
    MORAN, M
    RN MAGAZINE, 1983, 46 (12): : 71 - 71
  • [50] Semaglutide: Weight loss craze brings enormous profits to the pharmaceutical industry
    Eversmann, Thomas
    DIABETOLOGIE, 2023, 19 (08): : 955 - 956
12345